Overview

Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To study the effect of sibutramine treatment on weight reduction and blood pressure improvement in three groups with antihypertensive therapy whose blood pressure was not adequately controlled with antihypertensive combination treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Abbott
Treatments:
Antihypertensive Agents
Felodipine
Metoprolol
Ramipril
Sibutramine
Trandolapril
Verapamil